info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » pharmaceuticals

pharmaceuticals

Blood Plasma Derivatives Market By Product Type (Immunoglobulins, Albumin, Clotting Factor Concentrates, Other Plasma Derivatives); By Application (Immunology, Hematology, Neurology, Other Applications); By End User (Hospitals, Blood Banks, Pharmaceutical Manufacturers, Diagnostic Centers, Clinics & ASCs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Blood Plasma Derivatives Market is poised to experience a robust growth trajectory, with a CAGR of 7.4% from 2024 to 2030. This market, valued at approximately ... Read More

Published Date: AUG-2025 | No Of Pages:179 | $ 4485

Progressive Supranuclear Palsy Market by Treatment Type (Drug Therapy, Physical Therapy, Surgical Interventions); By End User (Hospitals, Ambulatory Surgical Centers, Research Institutions, Diagnostic Imaging Centers); By Diagnostic Method (MRI and CT Scans, Genetic Testing, Biomarker Detection); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Progressive Supranuclear Palsy M arket will experience a steady growth trajectory with a projected CAGR of approximately 5.2% from 2024 to 2030. PSP, a rare a... Read More

Published Date: AUG-2025 | No Of Pages:180 | $ 4485

Pediatric Epilepsy Therapeutics Market By Drug Type (Anti-Epileptic Drugs, Gene Therapy, Neurostimulation Devices, Ketogenic Diet); By Treatment Modality (Pharmacological Treatment, Surgical Treatment, Neurostimulation); By End User (Childrens Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Pediatric Epilepsy Therapeutics Market is on track to experience significant growth, with an expected CAGR of 6.5% , valued at approximately USD 5.2 billion in 2024 , and projected to reach USD 8.7 billion by 2030 , confirms S... Read More

Published Date: AUG-2025 | No Of Pages:162 | $ 4485

Epidermolysis Bullosa (EB) Treatment Market By Treatment Type (Gene Therapy, Stem Cell Therapy, Topical Therapies, Enzyme Replacement Therapy); By Therapeutic Approach (Gene Editing, Symptomatic Treatment, Combination Therapies); By End User (Children’s Hospitals, General Hospitals, Diagnostic Clinics, Home Healthcare Providers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Epidermolysis Bullosa Treatment Market is expected to grow at a robust compound annual growth rate (CAGR) of 8.5% , with the market valued at approximately USD ... Read More

Published Date: AUG-2025 | No Of Pages:189 | $ 4485

Endocrinology Drugs Market By Product Type (Insulin Therapies, Thyroid Hormone Replacement, Corticosteroids, Other Hormone Replacement Drugs); By Application (Diabetes, Thyroid Disorders, Adrenal Disorders, Other Endocrine Disorders); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Diagnostic Imaging Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Endocrinology Drugs Market is poised for considerable growth, driven by an increasing prevalence of endocrine-related diseases such as diabetes, thyroid disorders, and adrenal insufficiencies. Valued at Read More

Published Date: AUG-2025 | No Of Pages:172 | $ 4485

Antidiuretic Drugs Market By Product Type (Desmopressin, Vasopressin, Others); By Indication (Diabetes Insipidus, SIADH); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Antidiuretic Drugs Market will experience significant growth, with a CAGR of 6.5% , projected to reach USD 7.3 billion by 2030 from USD 4.2 bil... Read More

Published Date: AUG-2025 | No Of Pages:200 | $ 4485

Generic Drugs Market By Drug Type (Prescription Generics, OTC Generics); By Therapeutic Area (Cardiovascular, Oncology, Diabetes, Infectious Diseases, Others); By Market Type (Branded Generics, Non-branded Generics); By Region, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Generic Drugs Market is anticipated to experience substantial growth, projected to expand at a CAGR of approximately 6.8% from 2024 to 2030 , with an e... Read More

Published Date: AUG-2025 | No Of Pages:177 | $ 4485

Legal Cannabis Market By Product Type (Flower, Concentrates, Edibles & Beverages, Topicals & Tinctures); By Application (Medical Use, Recreational Use); By Compound Type (THC-Dominant, CBD-Dominant, Balanced); By Distribution Channel (Dispensaries, Pharmacies, Online, Wellness Retailers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Legal Cannabis Market is projected to expand at a CAGR of 13.6% , valued at USD 42.3 billion in 2024 and expected to reach around USD 102.1 bil... Read More

Published Date: AUG-2025 | No Of Pages:186 | $ 4485

Cleanroom Consumables Market By Product Type (Cleanroom Apparel, Cleaning & Disinfection Products, Sterilization Consumables, Air Filtration Products, Other Consumables); By Application (Pharmaceutical & Biotechnology, Semiconductors & Electronics, Aerospace & Defense, Medical Devices, Other Applications); By End User (Pharmaceutical Companies, Semiconductor Manufacturers, Medical Device Manufacturers, Contract Manufacturing Organizations, Hospitals & Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Cleanroom Consumables Market is projected to experience steady growth, with a CAGR of 7.8 % , valued at approximately USDRead More

Published Date: AUG-2025 | No Of Pages:187 | $ 4485

Pharmaceutical Filtration Market By Product Type (Membrane Filters, Depth Filters, Cartridge Filters, Syringe Filters, Capsule Filters, Filter Holders); By Technique (Microfiltration, Ultrafiltration, Nanofiltration, Crossflow, Vacuum Filtration); By Application (Final Product Processing, Raw Material Filtration, Cell Separation, Water Purification, Air/Gas Filtration); By End User (Pharmaceutical & Biopharmaceutical Companies, CMOs/CDMOs, Academic & Research Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Pharmaceutical Filtration Market is projected to reach USD 21.4 billion by 2030 , up from an estimated USD 11.9 billion in 2024 , growing at a steady <... Read More

Published Date: AUG-2025 | No Of Pages:191 | $ 4485

Janus Kinase (JAK) Inhibitors Market By Drug Type (Pan-JAK Inhibitors, Selective JAK Inhibitors); By Application (Rheumatology, Dermatology, Gastroenterology, Hematology & Oncology); By Route of Administration (Oral, Topical); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Janus Kinase (JAK) Inhibitors Market will witness a steady CAGR of 9.1% , valued at USD 18.7 billion in 2024 , and expected to grow to USD 31.2... Read More

Published Date: AUG-2025 | No Of Pages:195 | $ 4485

Hyperkalemia Treatment Market By Treatment Type (Potassium Binders, Diuretics & Others, Acute Rescue Therapies); By Disease Association (Chronic Kidney Disease, Heart Failure, Diabetes Mellitus); By Route of Administration (Oral, Intravenous); By End User (Hospitals, Outpatient Clinics, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Hyperkalemia Treatment Market is poised for a steady climb, projected to grow at a CAGR of 6.8% , with a market value of approximately USD 1.34 billion in 2024 , and ex... Read More

Published Date: AUG-2025 | No Of Pages:198 | $ 4485

Atherosclerosis Drugs Market By Drug Type (Statins, PCSK9 Inhibitors, Antiplatelet Drugs, Anti-inflammatory Drugs, Cholesterol Absorption Inhibitors); By Therapeutic Application (Primary Prevention, Secondary Prevention, Acute Treatment); By Region, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Atherosclerosis Drugs Market is poised for notable growth, with a projected compound annual growth rate (CAGR) of approximately 6.3% from 2024 to 2030, reaching an esti... Read More

Published Date: AUG-2025 | No Of Pages:193 | $ 4485

Viral Vector Manufacturing Market By Vector Type (Adenoviral, Adeno-Associated Viral [AAV], Lentiviral, Retroviral, Others); By Workflow Stage (Upstream Processing, Downstream Processing, Quality Control & Analytics); By Application (Gene Therapy, Cell Therapy, Vaccinology, Oncology Research, Infectious Disease Therapeutics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

The Global Viral Vector Manufacturing Market will witness a robust CAGR of 15.8%, valued at $1.85 billion in 2024, and is expected to appreciate significantly to reach $4.46 billion by 2030, confirms St... Read More

Published Date: JUL-2025 | No Of Pages:181 | $ 4485

Therapeutic Drug Monitoring Market By Product Type (Consumables, Instruments, Software & Services); By Technology (Immunoassays, Chromatographic Techniques); By End User (Hospitals, Diagnostic Laboratories, Academic & Research Institutes, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Therapeutic Drug Monitoring Market will witness a robust CAGR of 10.1% , valued at $2.16 billion in 2024 , expected to appreciate and reach $3.82 billion by 2030 , confirm... Read More

Published Date: JUL-2025 | No Of Pages:194 | $ 4485

Protein Binding Assays Market By Product Type (Consumables, Instruments, Software & Services); By Technique (Equilibrium Dialysis, Ultrafiltration, Surface Plasmon Resonance, Others); By Application (Preclinical Drug Development, Clinical Pharmacokinetics, Toxicology, Biologics Profiling); By End User (Pharmaceutical & Biotechnology Companies, CROs, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Protein Binding Assays Market will witness a robust CAGR of 9.1% , valued at $630 million in 2024 , and is expected to appreciate and reach $1.06 billion by 2030 , confirm... Read More

Published Date: JUL-2025 | No Of Pages:199 | $ 4485

Nuclear Magnetic Resonance Spectroscopy Market By Product Type (High-Resolution NMR, Benchtop NMR, Cryoprobes, Software); By Application (Drug Discovery, Metabolomics, Food Testing, Diagnostics); By End User (Pharma & Biotech, Academic Institutes, Hospitals, Testing Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Nuclear Magnetic Resonance (NMR) Spectroscopy Market will witness a robust CAGR of 7.1% , valued at USD 1.32 billion in 2024 , and is expected to appreciate and reach USD 1.98 bill... Read More

Published Date: JUL-2025 | No Of Pages:165 | $ 4485

Tangential Flow Filtration Market By Product Type (Single-use Systems, Reusable Systems, Membrane Filters, Accessories); By Membrane Material (PES, Cellulose, PVDF, Others); By Application (Protein Purification, Vaccine Production, Antibody Production, Nucleic Acid Purification, Others); By End User (Biopharma Companies, CMOs/CROs, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

The Global Tangential Flow Filtration Market will witness a robust CAGR of 11.8%, valued at $3.74 billion in 2024, expected to appreciate and reach $7.06 billion by 2030, confirms Strategic Market Research. This surge is fueled by escal... Read More

Published Date: JUL-2025 | No Of Pages:186 | $ 4485

Adeno-Associated Virus (AAV) Vector Manufacturing Market By Vector Type (Single-Stranded AAV, Self-Complementary AAV); By Application (Gene Therapy, Cell Therapy, Vaccinology, Research Use); By Manufacturing Platform (Plasmid Transfection, Baculovirus/Insect Cell System, HSV-Based System, Stable Producer Cell Lines); By End User (Biopharmaceutical & Biotechnology Companies, Academic & Research Institutions, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1: Introduction and Strategic Context

The Global Adeno-Associated Virus (AAV) Vector Manufacturing Market will witness a robust CAGR of 17.6%, valued at $4.6 billion in 2024, and is expected to appreciate and reach $12.17 billion by 2030, confirms Strategic Market Res... Read More

Published Date: JUL-2025 | No Of Pages:163 | $ 4485

G-Protein Coupled Receptors (GPCRs) Market By Drug Class (Agonists, Antagonists, Inverse Agonists, Allosteric Modulators); By Therapeutic Area (Oncology, Cardiovascular, CNS, Metabolic, Immunology); By Molecule Type (Small Molecules, Biologics, Peptides); By End User (Pharma & Biotech, CROs, Academic, Diagnostics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global G - Protein Coupled Receptors ( Gpcrs ) Market will witness a robust CAGR of 6.9% , valued at approx... Read More

Published Date: JUL-2025 | No Of Pages:191 | $ 4485

DNA Repair Drugs Market By Drug Class (PARP Inhibitors, ATM/ATR Inhibitors, DNA-PK Inhibitors, CHK1/CHK2 Inhibitors, Others); By Application (Breast Cancer, Ovarian Cancer, Prostate Cancer, Pancreatic Cancer, Others); By End User (Hospitals, Specialty Cancer Centers, Academic & Research Institutes, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global DNA Repair Drugs Market will witness a robust CAGR of 11.4% , valued at $5.6 billion in 2024 , expected to appreciate and reach $10.7 billion by 2... Read More

Published Date: JUL-2025 | No Of Pages:191 | $ 4485

Recombinant Cell Culture Supplements Market By Product Type (Recombinant Albumin, Recombinant Insulin, Recombinant Transferrin, Recombinant Growth Factors, Others); By Application (Biopharmaceutical Production, Stem Cell Therapy, Gene Therapy, Vaccine Manufacturing, R&D); By End User (Biopharmaceutical Companies, CDMOs, Academic & Research Institutes, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Recombinant Cell Culture Supplements Market will witness a robust CAGR of 11.7% , valued at $468.2 million in 2024 , and is expected to appreciate and reach approximately $890.4 million by 2030 , confirms Strategic Market Research<... Read More

Published Date: JUL-2025 | No Of Pages:165 | $ 4485

Interventional Oncology Market By Product Type (Ablation Devices, Embolization Devices, Supportive Products); By Procedure Type (Thermal Ablation, Non-Thermal Ablation, Embolization); By Cancer Type (Liver, Lung, Kidney, Bone & Others); By End User (Hospitals, Clinics, Academic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Interventional Oncology Market will witness a robust CAGR of 7.5%, valued at $3.85 billion in 2024, expected to appreciate and reach $5.94 billion by 2030, confirms Strategic Market Research.

Interventional on... Read More

Published Date: JUL-2025 | No Of Pages:193 | $ 4485

Erectile Dysfunction Drugs Market By Drug Type (PDE5 Inhibitors, Hormone-Based Therapies, Alprostadil, Herbal & Others); By Route of Administration (Oral, Injectable, Topical, Sublingual, Intranasal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Erectile Dysfunction Drugs Market will witness a steady CAGR of 5.6%, valued at USD 3.75 billion in 2024, and is expected to appreciate and reach USD 5.18 billion by 2030, confirms Strategic Market Research.

&nbs... Read More

Published Date: JUL-2025 | No Of Pages:150 | $ 4485

U.S. ADHD Controlled Substances Market By Drug Class (Amphetamine-Based Stimulants, Methylphenidate-Based Stimulants); By Age Group (Pediatric, Adolescent, Adult); By Distribution Channel (Retail Pharmacies, Online and Mail-Order Pharmacies, Institutional and Closed-Door Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

TABLE OF CONTENTS
PART I: MARKET INTELLIGENCE FRAMEWORK AND STRATEGIC CONTEXT
1.    RESEARCH FRAMEWORK AND MARKET SCOPE ALIGNMENT
1.1. Defining the Research Scope
1.1.1. ADHD Therapeutic Overview and Market Boundaries
1.1.2. Focus on Schedule II Contro... Read More

Published Date: JUL-2025 | No Of Pages:150 | $ 1500

Topical Drugs CDMO Market By Service Type (Formulation Development and Preclinical Services, Commercial Manufacturing, Analytical and Regulatory Support); By Product Type (Creams and Ointments, Gels and Lotions, Transdermal Patches, Foams and Sprays); By Therapeutic Application (Dermatological Disorders, Pain Management, Hormone Replacement and Oncology, Aesthetic Dermatology and Cosmeceuticals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

The Global Topical Drugs CDMO Market represents a vital segment of the broader pharmaceutical outsourcing industry, encompassing the contract development and manufacturing of dermatological, transdermal, and mucosal drug formulations... Read More

Published Date: JUL-2025 | No Of Pages:150 | $ 4485

Drug Abuse Testing Market By Product Type (Analytical Instruments, Rapid Testing Devices, Consumables); By Sample Type (Urine, Blood, Oral Fluid, Hair, Sweat); By End User (Hospitals & Labs, Workplace, Law Enforcement, Education, Home Users); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

The Global Drug Abuse Testing Market will witness a robust CAGR of 6.8%, valued at $6.4 billion in 2024, and is expected to appreciate and reach $9.5 billion by 2030, confirms Strategic Market Research.

Drug abus... Read More

Published Date: Jul-2025 | No Of Pages:150 | $ 4485

Multiplex Assays Market By Product Type (Nucleic Acid Assays, Protein Assays, Cell-Based Assays, Others); By Application (Clinical Diagnostics, Research and Development, Drug Discovery and Development, Others); By End-User (Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Research and Academic Institutes); By Geography, Segment revenue estimation, Forecast, 2023-2030

Industry Report and Statistics (Facts & Figures) - Sales Volume & ASP by Product Type & Technology

 

The global multiplex assays market will witness a robust CAGR of 11.2%, valued at $2.5 billion in 2022, and expect... Read More

Published Date: Mar-2022 | No Of Pages:135 | $ 4485